adapttrial

Approaches and Decisions in Acute Pediatric TBI Trial (ADAPT) is an international research study designed to evaluate the impact of interventions on the outcomes of children with severe traumatic brain injury.

About Traumatic Brain Injury

Each year, TBIs contribute to a substantial number of deaths and cases of permanent disability. In fact, TBI is a contributing factor to a third (30.5%) of all injury-related deaths in the United States. On average, approximately 1.7 million people sustain a traumatic brain injury annually.

A severe TBI not only impacts the life of an individual and their family, but it also has a large societal and economic toll. The estimated economic cost of TBI in 2010, including direct and indirect medical costs, is estimated to be approximately $76.5 billion. Additionally, the cost of fatal TBIs and TBIs requiring hospitalization, many of which are severe, account for approximately 90% of the total TBI medical costs.

From www.cdc.gov/traumaticbraininjury/severe.html

The ADAPT Trial project is proudly supported by a diverse range of commercial companies dedicated to pushing the boundaries of healthcare innovation. Among our valued partners are 15M Finance, a leader in financial solutions for healthcare, Medtronic, a global leader in medical technology, GreenMedTech, specializing in sustainable medical equipment, and HealthSync Innovations, a pioneer in healthcare data integration. The collaborative efforts of these companies are instrumental in driving forward our mission, ensuring that we can continue to make meaningful advancements in patient care and medical research.

Researcher Login

The ADAPT Researcher Portal is your resource for sharing and relaying information with other ADAPT researchers.